Liver fibrosis is strongly associated with an enhanced level of immunosuppressive tryptophan catabolism independently of HCV viremia in ART-treated HIV/HCV co-infected patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Liver fibrosis is strongly associated with an enhanced level of immunosuppressive tryptophan catabolism independently of HCV viremia in ART-treated HIV/HCV co-infected patients ; volume:14 ; number:2 ; day:23 ; month:5 ; year:2014 ; pages:1-2 ; date:5.2014
BMC infectious diseases ; 14, Heft 2 (23.5.2014), 1-2, 5.2014
- Creator
-
Jenabian, Mohammad-Ali
- Contributor
-
Kema, Ido
Ramirez, Robert Paulino
Saeed, Sahar
Rollet, Kathleen
Vyboh, Kishanda
Tejada, Jean-Carlos
Gilmore, Norbert
Klein, Marina B.
Routy, Jean-Pierre
SpringerLink (Online service)
- DOI
-
10.1186/1471-2334-14-S2-O16
- URN
-
urn:nbn:de:1111-2016030321366
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jenabian, Mohammad-Ali
- Kema, Ido
- Ramirez, Robert Paulino
- Saeed, Sahar
- Rollet, Kathleen
- Vyboh, Kishanda
- Tejada, Jean-Carlos
- Gilmore, Norbert
- Klein, Marina B.
- Routy, Jean-Pierre
- SpringerLink (Online service)
Other Objects (12)
Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients
Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg
German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients
Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users
Hepatitis C treatment initiation in HIV-HCV coinfected patients
Effectiveness of ombitasvir/paritaprevir/ritonavir, dasabuvir for HCV in HIV/HCV coinfected subjects: a comprehensive analysis
Efficacy and tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected patients with psychiatric disorders
Contemporary HCV pangenotypic DAA treatment protocols are exclusionary to real world HIV-HCV co-infected patients
FTOrs9939609 polymorphism is associated with metabolic disturbances and response to HCV therapy in HIV/HCV-coinfected patients
Identification of the transcripts associated with spontaneous HCV clearance in individuals co-infected with HIV and HCV
Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients
Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg
German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients
Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users
Hepatitis C treatment initiation in HIV-HCV coinfected patients
Effectiveness of ombitasvir/paritaprevir/ritonavir, dasabuvir for HCV in HIV/HCV coinfected subjects: a comprehensive analysis
Efficacy and tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected patients with psychiatric disorders
Contemporary HCV pangenotypic DAA treatment protocols are exclusionary to real world HIV-HCV co-infected patients
FTOrs9939609 polymorphism is associated with metabolic disturbances and response to HCV therapy in HIV/HCV-coinfected patients
Identification of the transcripts associated with spontaneous HCV clearance in individuals co-infected with HIV and HCV
Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients
Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg
German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients
Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users
Hepatitis C treatment initiation in HIV-HCV coinfected patients
Effectiveness of ombitasvir/paritaprevir/ritonavir, dasabuvir for HCV in HIV/HCV coinfected subjects: a comprehensive analysis
Efficacy and tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected patients with psychiatric disorders
Contemporary HCV pangenotypic DAA treatment protocols are exclusionary to real world HIV-HCV co-infected patients
FTOrs9939609 polymorphism is associated with metabolic disturbances and response to HCV therapy in HIV/HCV-coinfected patients